entertainment -WSS

entertainment

author：Wikipedia 2025-10-02 11:07:31 - browse：39

Stock exchange — Drew Angerer/Getty Images

Sage Therapeutics said Monday that it may need to reduce costs, including through employee layoffs, following the Food and Drug Administration’s denial of its rapid-acting drug for major depressive disorder.

On Friday, the agency granted market clearance for the drug, called Zurzuvae, to treat women with postpartum depression, a smaller commercial market. Sage failed to convince regulators to also approve the drug for depression, a broader condition.

“We don’t agree with the FDA review,” Sage CEO Barry Greene said during an earnings call, a point he made repeatedly. “We are evaluating the [FDA’s response letter] and as soon as we can provide more clarity, we will, on what the next steps are.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： It was time to plan for my old age. If only I could stop crying

WSS

The PBM ad wars are taking over Washington, D.C.

Rare Northern Lights show in US this week: Where and how to see it

Kansas must stop changing trans people's sex listing on driver's licenses, judge says

Failure, not just success, should guide future doctors

Trump used to be more articulate. What could explain the change?

Ahead of NATO summit, Biden meets with King Charles for 1st time since coronation

Wikipedia

entertainment

focus

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

'Brian's Song' at 50 still offers lessons about cancer for today

Cancer drug shortages should be causing more outrage

McConnell is warmly embraced by Kentucky Republicans amid questions about his health

Bright Health sells Medicare Advantage business to Molina

What could happen if Russia blows up the Zaporizhzhia Nuclear Power Plant?

Medicare proposal to cover medical devices draws a mixed reaction

Trump used to be more articulate. What could explain the change?

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Paxlovid rebound happens. Why and to whom are still a mystery

hotspot

How CRISPR works, explained in two minutes

Feed a cold, starve a fever? Here’s what science says

Masked men burn a market in a Mexican city plagued by gang violence, killing 9 people

Election results set back Medicaid expansion plans

Drinking water from half of US faucets contains PFAS: Study

McConnell is warmly embraced by Kentucky Republicans amid questions about his health

hotspot

entertainment

focus

hotspot